The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-Benzyloxy-3-cyano)phenylpyrimidine-4-ol ID: ALA4878323
PubChem CID: 164626053
Max Phase: Preclinical
Molecular Formula: C18H13N3O2
Molecular Weight: 303.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1cc(-c2nccc(O)n2)ccc1OCc1ccccc1
Standard InChI: InChI=1S/C18H13N3O2/c19-11-15-10-14(18-20-9-8-17(22)21-18)6-7-16(15)23-12-13-4-2-1-3-5-13/h1-10H,12H2,(H,20,21,22)
Standard InChI Key: WWKUBQRZGLBZIU-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
17.9685 -11.5727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9674 -12.3922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6754 -12.8012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3851 -12.3918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3823 -11.5691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6736 -11.1639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0854 -11.1591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7949 -11.5668 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5006 -11.1562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4980 -10.3381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7838 -9.9324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0810 -10.3453 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2594 -12.8003 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6782 -13.6189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6780 -14.4361 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7778 -9.1152 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.5520 -12.3911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8439 -12.7992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1373 -12.3878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4298 -12.7952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4287 -13.6132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1410 -14.0222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8457 -13.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
5 7 1 0
2 13 1 0
14 15 3 0
3 14 1 0
11 16 1 0
13 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 303.32Molecular Weight (Monoisotopic): 303.1008AlogP: 3.30#Rotatable Bonds: 4Polar Surface Area: 79.03Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.55CX Basic pKa: 0.94CX LogP: 4.13CX LogD: 4.13Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.80Np Likeness Score: -1.33
References 1. Sun M, Zhao J, Mao Q, Yan C, Zhang B, Yang Y, Dai X, Gao J, Lin F, Duan Y, Zhang T, Wang S.. (2021) Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenylpyrimidine derivatives with 4-amino or 4-hydroxy as a pharmacophore element binding with xanthine oxidase active site., 38 [PMID:33838610 ] [10.1016/j.bmc.2021.116117 ]